Silencing activating transcription factor 2 promotes the anticancer activity of sorafenib in hepatocellular carcinoma cells
2012 ◽
Vol 287
(23)
◽
pp. 19599-19609
◽
2018 ◽
Vol 135
◽
pp. 188-200
◽
2015 ◽
Vol 12
(3)
◽
pp. 3869-3873
◽
2016 ◽
2013 ◽
Vol 33
(6)
◽
pp. 862-865
◽
2000 ◽
Vol 2
(2)
◽
pp. 117-127
◽